Shots:
With more than 50% of ongoing clinical trials worldwide in oncology domains, cancer remains one of the leading causes of death worldwide. Oncology companies are steadfastly looking for innovative therapies to cure both hematologic and solid tumor cancer
The global oncology drug market size in 2022 was valued at $185B and is forecasted to…
“The supreme art of war is to subdue the enemy without fighting” – Sun Zhu, Competitive Intelligence benefits your organization gather and analyzing information related to your competitor’s business models. This deep analysis helps your organization reduce the strategic risks and increase revenue opportunities by attaining deep insights into how the market has changed and…
In an interview with PharmaShots, Ray Lee, CEO at Teclison shared his views on the completion of a $5.9 million capital raise and advancement of its oncology drug portfolio
Shots:
Ray spoke about Teclison’s recently completed funding of $5.9 million led by W.T.T. Investment
He focused on the development of the lead candidate in the…

